Results for
"[search-keyword]"
Sponsor content
310 result(s) found, displaying 101 to 110
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Australian Public Assessment Report (AusPAR)Enhertu (trastuzumab deruxtecan) for treatment of unresectable or metastatic HER2 positive breast cancer.
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMEPRAZOLE MUPS AZN omeprazole 10 mg (as magnesium) tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMEPRAZOLE MUPS AZN omeprazole 20 mg (as magnesium) tablet blister pack.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Budesonide / glycopyrronium / formoterol
-
Prescription medicine decision summaryTGA Decision: Saphnelo (anifrolumab) is approved to treat adult patients with active systemic lupus erythematosus (SLE).
-
Australian Public Assessment Report (AusPAR)Forxiga (dapagliflozin) has been approved for reducing the risk of progressive decline in kidney function in adults with
proteinuric chronic kidney disease. -